Committees

Agenda for the 184th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 3 DECEMBER 2020, at 9 am

1.	MATTERS OF ADMINISTRATION
1.1	Welcome and apologies
1.2	Minutes and recommendations of the 183rd MARC meeting
1.3	Declarations of potential conflicts of interest
2.	MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE
2.1	CARM quarterly report
3.	PHARMACOVIGILANCE REPORTS
3.1	Matters referred to the MARC by Medsafe under section 36 of the Medicines Act 1981
	No items
3.2	Matters referred to the MARC by Medsafe
	3.2.1 Gabapentin and pregabalin safety review
	3.2.2 Opioids and abuse, misuse and dependence
	3.2.3 HER2- and CD receptor-targeted monoclonal antibodies and the risk of interstitial lung disease
	3.2.4 Tricyclic antidepressants and the risk of congenital malformation
4.	MEDSAFE PHARMACOVIGILANCE ACTIVITIES
4.1	Report on standing agenda items
4.2	Medsafe pharmacovigilance activities
4.3	Prescriber Update
4.4	Quarterly summary of recent safety communications